Authors


Elizabeth Harari, MD

Latest:

Research Sheds Light on Two Types of Treatment for ADHD

New research highlights the potential benefits and detriments of treatment strategies for ADHD, including both pharmacological and nonpharmacological options.


Vivek Datta, MD, MPH

Latest:

Introduction: Exploring the Foundations of Psychiatry

As we discover new diseases of the brain that present with psychiatric symptoms, it remains incumbent upon us to remember the experience of patients and their families in the context of society at large.


Scott Beach, MD

Latest:

Neuropsychiatry of Catatonia: Clinical Implications

As a neuropsychiatric and general medical syndrome, catatonia represents an important diagnostic and treatment challenge for all clinicians given its morbidity and mortality.


Gregory Fricchione, MD

Latest:

Mini Quiz: Malignant Catatonia

What is the best treatment for malignant catatonia, which is characterized by catatonic symptoms plus fever and hyperautonomia and is associated with significant morbidity and mortality? Take the quiz.


Gertie Quitangon, MD

Latest:

Managing Distress in Health Care Workers During COVID-19: Lessons From a Disaster Trauma Lens

We have learned that in order to provide much-needed social support during difficult times, organizations should prepare to take certain steps.


Ken Duckworth, MD

Latest:

Helping Complex Patients

The National Alliance on Mental Illness (NAMI) is a one-of-a-kind nonprofit that is here for your patients and their families, no matter where they are.


Christine Allen

Latest:

Helping Complex Patients

The National Alliance on Mental Illness (NAMI) is a one-of-a-kind nonprofit that is here for your patients and their families, no matter where they are.


Benjamin Tolchin, MD, MS

Latest:

Mini Quiz: The Truth About Psychogenic Nonepileptic Seizures

PNES cause significant suffering, and most patients with undiagnosed and/or untreated PNES continue to have seizures and remain on disability. What do we know about PNES? Take the quiz and learn more.


Hamada Altalib, DO, MPH

Latest:

Addressing Psychogenic Nonepileptic Seizures: Clinical Challenges

DSM-5 categorizes PNES as a functional neurological disorder or conversion disorder with seizures. It is essential that neurologists, psychiatrists, and other clinicians coordinate care to ensure that patients with PNES receive a prompt diagnosis.


Carissa Cabán-Alemán, MD

Latest:

Puerto Rico Se Levanta (“Puerto Rico Rises”): From Denial and Passivity to Action and Hope

Hurricane Maria was the wakeup call many Puerto Ricans needed to become active in social justice efforts. Their story serves as an example of transformational resilience.


Coreen B. Domingo, DrPH

Latest:

Cannabinoids for Chronic Pain: An Opioid Alternative?

The cannabinoids (particularly CBD) have been hailed as non-addictive solutions to using escalating doses of opioids for chronic pain. More in this research update.


Jonathan R. Scarff, MD

Latest:

How Can Psychiatrists Become Better Negotiators?

Use these strategies to facilitate beneficial outcomes for patients, improve relationships with colleagues, and enhance workplace satisfaction.


Joseph R. Sanok, MA, LLP, LPC, NCC

Latest:

Making Your Practice Work for You

By releasing old assumptions and brainstorming, it is possible to break the old models of private practice and find new ways to be productive within your practice.


Amresh Shrivastava, MD

Latest:

Polypharmacy: A Challenge for Community Psychiatrists

Polypharmacy has been met with challenges because many practicing clinical guidelines and treatment algorithms prefer a monotherapy approach.


Avinash De Sousa, MD

Latest:

Polypharmacy: A Challenge for Community Psychiatrists

Polypharmacy has been met with challenges because many practicing clinical guidelines and treatment algorithms prefer a monotherapy approach.


Pragya Lodha, MA

Latest:

Polypharmacy: A Challenge for Community Psychiatrists

Polypharmacy has been met with challenges because many practicing clinical guidelines and treatment algorithms prefer a monotherapy approach.


Sergi Ferré, MD, PhD

Latest:

Caffeine: Neurobiological and Psychiatric Implications

This CME article discusses the pharmacokinetics of caffeine and its implications on anxiety.


Robert Caudill, MD

Latest:

The History and Value of Guidelines for Best Practices of Telemental Health

Telepsychiatry has its origins in the 1950s and has moved from an esoteric curiosity to mainstream practice. However, it has been challenged along the way at many turns.


Heidi C. Collins, MD

Latest:

Recognizing and Treating Comorbid Psychiatric Disorders in People With Autism

While the core features of autism impair functioning, a significant source of further impairment is comorbid psychiatric disorders.


Matthew S. Siegel, MD

Latest:

Recognizing and Treating Comorbid Psychiatric Disorders in People With Autism

While the core features of autism impair functioning, a significant source of further impairment is comorbid psychiatric disorders.


Arman Fesharaki-Zadeh, MD, PhD

Latest:

4 Stages of Chronic Traumatic Encephalopathy

A 59-year-old man with a history of multiple concussions has been having a series of neurocognitive symptoms for the past several years. Discover more in this case.


Zeina Chemali, MD, MPH

Latest:

5 Psychopharmacologic Approaches to Treating Tinnitus

Tinnitus affects 50 million people in the US and can require urgent medical assistance. It can also cause considerable anxiety and even hallucinations. Reducing symptom intensity is key.


Romy Nehme, MD

Latest:

5 Psychopharmacologic Approaches to Treating Tinnitus

Tinnitus affects 50 million people in the US and can require urgent medical assistance. It can also cause considerable anxiety and even hallucinations. Reducing symptom intensity is key.


Ryan Vidrine, MD

Latest:

Integrating Deep Transcranial Magnetic Stimulation Into the OCD Treatment Algorithm

As our understanding of the neurobiology of OCD grows, additional treatment options become available and should be thoughtfully integrated into the treatment algorithm. One such option is dTMS.


Lorin Young, MD, MSc, FRCPC

Latest:

Green Spaces

Nature provides both physical and psychological benefits. How does this healing through exposure to nature occur?


Francisco González-Scarano, MD

Latest:

HIV-Associated Neurocognitive Disorder After the Start of Combination Antiretroviral Therapy

This CME article provides an understanding of the effects on the CNS that lead to HIV-associated neurocognitive disorders (HAND).


Dennis L. Kolson, MD, PhD

Latest:

HIV-Associated Neurocognitive Disorder After the Start of Combination Antiretroviral Therapy

This CME article provides an understanding of the effects on the CNS that lead to HIV-associated neurocognitive disorders (HAND).


John Oakley Beahrs, MD

Latest:

Undecidable Choices and the Polarization of Shared Ambivalence: What Can Psychiatry Add to Dispute Resolution?

Reframing is being tested as a potentially viable way to address intractable conflict where sacred values are at issue. In memory of Johan Verhulst, MD.


Hunter Yost, MD

Latest:

Cyclothymia, the Quintessential Mood Temperament: Ignored or Forgotten? Part III: Differentiating Cyclothymia and BPD and Treatment Considerations

In Part III of this series, an expert discusses the key differences between cyclothymia and borderline personality disorder, along with treatment considerations for cyclothymia.


Gen Tanaka, MD

Latest:

Transgenerational Transmission of Resilience After Catastrophic Trauma

In this CME, learn how to design interventions to promote resilience, study their relative effectiveness, and implement them accordingly.

© 2024 MJH Life Sciences

All rights reserved.